miR-29c-3p Regulates DNMT3B and LATS1 Methylation to Inhibit Tumor Progression in Hepatocellular Carcinoma

Cell Death and Disease - United Kingdom
doi 10.1038/s41419-018-1281-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

MiR-29c-3p, a Target miRNA of LINC01296, Accelerates Tumor Malignancy: Therapeutic Potential of a LINC01296/miR-29c-3p Axis in Ovarian Cancer

Journal of Ovarian Research
GynecologyOncologyObstetrics
2020English

Circular RNA MYLK Promotes Hepatocellular Carcinoma Progression by Increasing Rab23 Expression by Sponging miR-362-3p

Cancer Cell International
Cancer ResearchOncologyGenetics
2019English

MiR-3613-3p Affects Cell Proliferation and Cell Cycle in Hepatocellular Carcinoma

Oncotarget
Oncology
2017English

MiR-490-3p Inhibits Autophagy via Targeting ATG7 in Hepatocellular Carcinoma

IUBMB Life
BiochemistryGeneticsClinical BiochemistryCell BiologyMolecular Biology
2018English

miR‐124‐3p Availability Is Antagonized by LncRNA‐MALAT1 for Slug‐induced Tumor Metastasis in Hepatocellular Carcinoma

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

Clustered microRNAs Hsa-miR-221-3p/Hsa-miR-222-3p and Their Targeted Genes Might Be Prognostic Predictors for Hepatocellular Carcinoma

Journal of Cancer
Oncology
2019English

Downregulation of miR-29c-3p Is Associated With a Poor Prognosis in Patients With Laryngeal Squamous Cell Carcinoma

Diagnostic Pathology
Forensic MedicineMedicinePathologyHistology
2019English

Astrocyte Elevated Gene-1 Regulates Hepatocellular Carcinoma Development and Progression

Journal of Clinical Investigation
Medicine
2009English

A Comprehensive Insight Into the Clinicopathologic Significance of miR-144-3p in Hepatocellular Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy